HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antibody-onconase conjugates: cytotoxicity and intracellular routing.

Abstract
Onconase, a member of the pancreatic ribonuclease A superfamily, is currently in Phase III clinical trials for treatment of unresectable malignant mesothelioma. The anticancer effect of onconase may relate to its intracellular target, a non-coding RNA. Some non-coding RNAs are aberrantly expressed in cancer cells. This discovery is creating new interest in drugs that target RNA. Conjugating onconase to agents that recognize tumor associated molecules further increases its potency and specificity. Analysis of onconase activity when directed to two different internalizing and one non-internalizing receptor reveals that the ideal targeting agents would rapidly enter lysosomal compartments before onconase escaped to the cytosol. Antibody-onconase conjugates are effective in preclinical models, cause little non-specific toxicities in mice and have favorable formulation properties. Understanding the reason for their potency coupled with understanding novel RNA-based mechanisms of tumor cell death will lead to improved variations of targeted onconase.
AuthorsS M Rybak
JournalCurrent pharmaceutical biotechnology (Curr Pharm Biotechnol) Vol. 9 Issue 3 Pg. 226-30 (Jun 2008) ISSN: 1873-4316 [Electronic] Netherlands
PMID18673288 (Publication Type: Journal Article, Review)
Chemical References
  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antibodies, Monoclonal
  • Immunoconjugates
  • Receptors, Transferrin
  • Sialic Acid Binding Ig-like Lectin 2
  • Ribonucleases
  • ranpirnase
Topics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 (immunology)
  • Animals
  • Antibodies, Monoclonal (administration & dosage, immunology, pharmacology, therapeutic use)
  • Cell Line, Tumor
  • Drug Delivery Systems
  • Endocytosis (drug effects)
  • Humans
  • Immunoconjugates (administration & dosage, immunology, pharmacology, therapeutic use)
  • Microbial Sensitivity Tests
  • Neoplasms (drug therapy, immunology, metabolism)
  • Receptors, Transferrin (immunology)
  • Ribonucleases (administration & dosage, immunology, pharmacology, therapeutic use)
  • Sialic Acid Binding Ig-like Lectin 2 (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: